文献速递临床试验与 GCP

苯磺酸瑞马唑仑与丙泊酚对心脏术后谵妄发生率影响的随机试验研究方案

Effect of remimazolam besylate compared with propofol on the incidence of delirium after cardiac surgery: study protocol for a randomized trial.
PubMed 文献 · Trials · 2021-10-18

本研究为前瞻性、双盲、随机对照临床试验,计划招募200例心脏手术患者,术后分别接受苯磺酸瑞马唑仑或丙泊酚输注至拔管,主要结局为术后5天内谵妄发生率,旨在评估瑞马唑仑是否较丙泊酚降低心脏术后谵妄发生率。

要点

  • 苯磺酸瑞马唑仑对比丙泊酚用于心脏术后镇静,主要结局为术后5天谵妄发生率。
  • 次要结局包括谵妄发生时间、持续时间、ICU住院时长、总住院时长和机械通气时间。
  • 该研究为初步随机对照试验,旨在检验瑞马唑仑降低心脏术后谵妄的假设。

核心结论

  • 本研究旨在评估苯磺酸瑞马唑仑是否较丙泊酚降低心脏手术患者术后谵妄发生率。

研究设计与样本

  • 前瞻性、双盲、随机对照临床试验,计划招募200例心脏手术患者。
  • 患者术后随机接受苯磺酸瑞马唑仑或丙泊酚输注,直至拔管。

关键数值与推荐

  • 主要结局为术后5天内谵妄发生率。
  • 次要结局包括谵妄发生时间、谵妄持续时间、ICU住院时长、医院住院时长和机械通气时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Delirium is an acute cognitive disorder that presents with fluctuation in cognition, apathy, and non-organized thinking, resulting in increased morbidity, mortality, intensive care unit (ICU) stay, and total healthcare costs. In patients undergoing cardiac surgery, delirium also increases the risk of postoperative complications, such as respiratory insufficiency, sternum instability, and need for re-operation of the sternum. This study aims to understand the incidence of delirium in patients after cardiac surgery in patients sedated with remimazolam besylate versus propofol. METHODS: In this prospective, double-blind, randomized controlled clinical trial, we aim to recruit 200 patients undergoing cardiac surgery between January 1, 2021, and December 31, 2021, who will be randomized to receive either remimazolam besylate or propofol infusions postoperatively, until they are extubated. The primary outcome is the incidence of delirium within 5 days after surgery. Secondary outcomes include the time of delirium onset, duration of delirium, ICU length of stay, hospital length of stay, and mechanical ventilation time. DISCUSSION: The key objective of this study is to assess whether remimazolam besylate reduces the incidence of delirium in patients after cardiac surgery compared to propofol sedation. In this preliminary randomized controlled clinical trial, we will test the hypothesis that the use of remimazolam besylate lowers the incidence of delirium when compared to propofol in patients undergoing cardiac surgery. TRIAL REGISTRATION: chictr.org.cn ChiCTR2000038976. Registered on October 11, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yang M, Liu X, Yang D, et al. Effect of remimazolam besylate compared with propofol on the incidence of delirium after cardiac surgery: study protocol for a randomized trial. Trials. 2021. PMID: 34663423. doi:10.1186/s13063-021-05691-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。